BIO-REFERENCE LABS INC - COM $.01 NEW (BRLI)

CUSIP: 09057G602

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM $.01 NEW
Total 13F shares
24,033,641
Share change
-897,136
Total reported value
$674,389,350
Put/Call ratio
300%
Price per share
$28.06
Number of holders
166
Value change
-$26,236,931
Number of buys
68
Number of sells
78

Quarterly Holders Quick Answers

What is CUSIP 09057G602?
CUSIP 09057G602 identifies BRLI - BIO-REFERENCE LABS INC - COM $.01 NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIO-REFERENCE LABS INC - COM $.01 NEW (BRLI) as of Q3 2014

As of 30 Sep 2014, BIO-REFERENCE LABS INC - COM $.01 NEW (BRLI) was held by 166 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,033,641 shares. The largest 10 holders included VANGUARD GROUP INC, RIVERBRIDGE PARTNERS LLC, ROYAL BANK OF CANADA, BlackRock Fund Advisors, BTIM Corp., Sarissa Capital Management LP, Epoch Investment Partners, Inc., Murphy Michael R, TIGER GLOBAL MANAGEMENT LLC, and BlackRock Institutional Trust Company, N.A.. This page lists 166 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.